2,2,4-trimethyl-1,2,3,4-tetrahydro-8-quinolinol, 95.0%, 1g

(R)-tert-Butyl 2-amino-3-cyclohexylpropanoate, 95%, 5g

3,5-Dibromo-N-(4-bromo-phenyl)-2-hydroxy-benzamide, 95.0%, 25g

(R)-3-((tert-Butoxycarbonyl)amino)-3-(m-tolyl)propanoic acid, 97%, 250mg

2,2,2-Trifluoro-1-(1,2,4,5-tetrahydro-7-nitro-1,5-methano-3H-3-benzazepin-3-yl)ethanone, 97%, 100mg

(S)-3-Aminopentanenitrile, 98%, 1g

2,3-Dimethoxyisonicotinaldehyde, 97%, 5g

Ethyl 4-amino-6-chloro-5-nitronicotinate, 95+%, 1g

(S)-2-((tert-butoxycarbonyl)amino)-3-(4-(pyridin-4-yl)phenyl)propanoic acid, 98%, 250mg

(S)-3-tert-Butoxycarbonylamino-4-methyl-pentanoic acid, 99.0%, 5g

Inkubator Heratherm Protocol Serie General Protocol mit natürlicher Konvektion, 194 l, IGS180, 1 Stück

6-Bromo-2-oxo-1,2-dihydro-3-quinolinecarbonitrile, 95.0%, 500mg

tert-butyl 4-methylbenzylcarbamate, 95%, 100g